Amore et al. [42] showed in vivo modulation of NFkB activation by N-acetyl-cysteine in DM patients on hemodialysis, suggesting a potential clinical benefit for the inhibition of oxidative stress pathways. The gene discussed is NFKB1; the disease is diabetes mellitus.